Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone, another hectic day is on the way. And this may be a soggy one, unfortunately. But we will persevere, nonetheless, as our spirits remain sunny. Once again, let us recall what the Morning Mayor used to say: Every brand new day should be unwrapped like a precious gift. How bad can a little rain and cloudy skies really be? While you ponder, here are some tidbits. As always, have a great day and do stay in touch... Glaxo Sells The Bad With The Good In New Safety Push (Bloomberg News) Bayer Seeks Wider Use For Eylea Eye Drug In Europe (Reuters) Novartis To Boost Boston R&D HQ By 150 Jobs (The Boston Globe) AstraZeneca Asks Court Not To Revive Medco Whistleblower Suit (Bloomberg News) AMRI Gets Closeout Letter For A Key Plant (Outsourcing Pharma) Top Adcock Shareholder Rejects CFR Pharma Bid (Reuters) FDA Updates Warning On Lovenox Bloodthinner Sold By Sanofi (Reuters) EDITOR'S NOTE: Please check this post for additional stories during the day Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs